Literature DB >> 30561649

Transcriptome alterations in myotonic dystrophy skeletal muscle and heart.

Eric T Wang1,2,3,4,5, Daniel Treacy1, Katy Eichinger6, Adam Struck7, Joseph Estabrook1,2,3,4,5, Hailey Olafson3,4,5, Thomas T Wang1, Kirti Bhatt6, Tony Westbrook8, Sam Sedehizadeh8, Amanda Ward9, John Day10, David Brook8, J Andrew Berglund3,4,5,7, Thomas Cooper9,11,12, David Housman1,2, Charles Thornton6, Christopher Burge1,2.   

Abstract

Myotonic dystrophy (dystrophia myotonica, DM) is a multi-systemic disease caused by expanded CTG or CCTG microsatellite repeats. Characterized by symptoms in muscle, heart and central nervous system, among others, it is one of the most variable diseases known. A major pathogenic event in DM is the sequestration of muscleblind-like proteins by CUG or CCUG repeat-containing RNAs transcribed from expanded repeats, and differences in the extent of MBNL sequestration dependent on repeat length and expression level may account for some portion of the variability. However, many other cellular pathways are reported to be perturbed in DM, and the severity of specific disease symptoms varies among individuals. To help understand this variability and facilitate research into DM, we generated 120 RNASeq transcriptomes from skeletal and heart muscle derived from healthy and DM1 biopsies and autopsies. A limited number of DM2 and Duchenne muscular dystrophy samples were also sequenced. We analyzed splicing and gene expression, identified tissue-specific changes in RNA processing and uncovered transcriptome changes strongly correlating with muscle strength. We created a web resource at http://DMseq.org that hosts raw and processed transcriptome data and provides a lightweight, responsive interface that enables browsing of processed data across the genome.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30561649      PMCID: PMC6452195          DOI: 10.1093/hmg/ddy432

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  33 in total

Review 1.  RNA-mediated neurodegeneration in repeat expansion disorders.

Authors:  Peter K Todd; Henry L Paulson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

2.  MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation.

Authors:  Julian P Venables; Laure Lapasset; Gilles Gadea; Philippe Fort; Roscoe Klinck; Manuel Irimia; Emmanuel Vignal; Philippe Thibault; Panagiotis Prinos; Benoit Chabot; Sherif Abou Elela; Pierre Roux; Jean-Marc Lemaitre; Jamal Tazi
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  Near-optimal probabilistic RNA-seq quantification.

Authors:  Nicolas L Bray; Harold Pimentel; Páll Melsted; Lior Pachter
Journal:  Nat Biotechnol       Date:  2016-04-04       Impact factor: 54.908

4.  GSK3β mediates muscle pathology in myotonic dystrophy.

Authors:  Karlie Jones; Christina Wei; Polina Iakova; Enrico Bugiardini; Christiane Schneider-Gold; Giovanni Meola; James Woodgett; James Killian; Nikolai A Timchenko; Lubov T Timchenko
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

5.  Alternative splicing dysregulation secondary to skeletal muscle regeneration.

Authors:  James P Orengo; Amanda J Ward; Thomas A Cooper
Journal:  Ann Neurol       Date:  2011-03-11       Impact factor: 10.422

6.  MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.

Authors:  Marianne Goodwin; Apoorva Mohan; Ranjan Batra; Kuang-Yung Lee; Konstantinos Charizanis; Francisco José Fernández Gómez; Sabiha Eddarkaoui; Nicolas Sergeant; Luc Buée; Takashi Kimura; H Brent Clark; Joline Dalton; Kenji Takamura; Sebastien M Weyn-Vanhentenryck; Chaolin Zhang; Tammy Reid; Laura P W Ranum; John W Day; Maurice S Swanson
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

7.  Splicing biomarkers of disease severity in myotonic dystrophy.

Authors:  Masayuki Nakamori; Krzysztof Sobczak; Araya Puwanant; Steve Welle; Katy Eichinger; Shree Pandya; Jeannne Dekdebrun; Chad R Heatwole; Michael P McDermott; Tian Chen; Melissa Cline; Rabi Tawil; Robert J Osborne; Thurman M Wheeler; Maurice S Swanson; Richard T Moxley; Charles A Thornton
Journal:  Ann Neurol       Date:  2013-12       Impact factor: 10.422

8.  Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.

Authors:  Ami Mankodi; Masanori P Takahashi; Hong Jiang; Carol L Beck; William J Bowers; Richard T Moxley; Stephen C Cannon; Charles A Thornton
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

9.  Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.

Authors:  N Muge Kuyumcu-Martinez; Guey-Shin Wang; Thomas A Cooper
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

10.  Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy.

Authors:  Marzena Wojciechowska; Krzysztof Sobczak; Piotr Kozlowski; Saam Sedehizadeh; Agnieszka Wojtkowiak-Szlachcic; Karol Czubak; Robert Markus; Anna Lusakowska; Anna Kaminska; J David Brook
Journal:  Sci Rep       Date:  2018-04-12       Impact factor: 4.379

View more
  38 in total

Review 1.  Repeat-associated RNA structure and aberrant splicing.

Authors:  Melissa A Hale; Nicholas E Johnson; J Andrew Berglund
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-16       Impact factor: 4.490

2.  Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy.

Authors:  Matthew K Tanner; Zhenzhi Tang; Charles A Thornton
Journal:  Nucleic Acids Res       Date:  2021-02-26       Impact factor: 16.971

3.  Excessive Sodium Intake Leads to Cardiovascular Disease by Promoting Sex-Specific Dysfunction of Murine Heart.

Authors:  Xiuli Chen; Haiying Wu; Shenzhen Huang
Journal:  Front Nutr       Date:  2022-07-01

4.  Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.

Authors:  Lydia Sharp; Diana C Cox; Thomas A Cooper
Journal:  Muscle Nerve       Date:  2019-10-23       Impact factor: 3.217

Review 5.  Molecular mechanisms underlying nucleotide repeat expansion disorders.

Authors:  Indranil Malik; Chase P Kelley; Eric T Wang; Peter K Todd
Journal:  Nat Rev Mol Cell Biol       Date:  2021-06-17       Impact factor: 113.915

6.  A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients.

Authors:  Max J F Degener; Remco T P van Cruchten; Brittney A Otero; Eric T Wang; Derick G Wansink; Peter A C 't Hoen
Journal:  NAR Genom Bioinform       Date:  2022-03-08

7.  Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes.

Authors:  Sumitava Dastidar; Debanjana Majumdar; Jaitip Tipanee; Kshitiz Singh; Arnaud F Klein; Denis Furling; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2021-08-08       Impact factor: 11.454

8.  Transcriptome alterations in myotonic dystrophy frontal cortex.

Authors:  Brittney A Otero; Kiril Poukalov; Ryan P Hildebrandt; Charles A Thornton; Kenji Jinnai; Harutoshi Fujimura; Takashi Kimura; Katharine A Hagerman; Jacinda B Sampson; John W Day; Eric T Wang
Journal:  Cell Rep       Date:  2021-01-19       Impact factor: 9.995

9.  Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.

Authors:  Kristin Strandberg; Burcu Ayoglu; Andreas Roos; Mojgan Reza; Erik Niks; Mirko Signorelli; Erik Fasterius; Fredrik Pontén; Hanns Lochmüller; Joana Domingos; Pierpaolo Ala; Francesco Muntoni; Annemieke Aartsma-Rus; Pietro Spitali; Peter Nilsson; Cristina Al-Khalili Szigyarto
Journal:  J Neuromuscul Dis       Date:  2020

10.  Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy.

Authors:  Melissa N Hinman; Jared I Richardson; Rose A Sockol; Eliza D Aronson; Sarah J Stednitz; Katrina N Murray; J Andrew Berglund; Karen Guillemin
Journal:  Dis Model Mech       Date:  2021-06-14       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.